- Home
- MVBF vs JSPR Comparison
MVBF vs JSPR Comparison
Compare MVBF & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MVBF
- JSPR
- Stock Information
- Founded
- MVBF 1997
- JSPR 2018
- Country
- MVBF United States
- JSPR United States
- Employees
- MVBF N/A
- JSPR N/A
- Industry
- MVBF Major Banks
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MVBF Finance
- JSPR Health Care
- Exchange
- MVBF Nasdaq
- JSPR Nasdaq
- Market Cap
- MVBF 282.7M
- JSPR 47.6M
- IPO Year
- MVBF N/A
- JSPR N/A
- Fundamental
- Price
- MVBF $24.34
- JSPR $2.38
- Analyst Decision
- MVBF Buy
- JSPR Buy
- Analyst Count
- MVBF 4
- JSPR 12
- Target Price
- MVBF $24.50
- JSPR $30.78
- AVG Volume (30 Days)
- MVBF 33.0K
- JSPR 150.8K
- Earning Date
- MVBF 10-29-2025
- JSPR 11-06-2025
- Dividend Yield
- MVBF 2.79%
- JSPR N/A
- EPS Growth
- MVBF N/A
- JSPR N/A
- EPS
- MVBF 1.29
- JSPR N/A
- Revenue
- MVBF $143,378,000.00
- JSPR N/A
- Revenue This Year
- MVBF N/A
- JSPR N/A
- Revenue Next Year
- MVBF $15.28
- JSPR N/A
- P/E Ratio
- MVBF $18.91
- JSPR N/A
- Revenue Growth
- MVBF N/A
- JSPR N/A
- 52 Week Low
- MVBF $15.59
- JSPR $2.27
- 52 Week High
- MVBF $25.13
- JSPR $26.05
- Technical
- Relative Strength Index (RSI)
- MVBF 59.74
- JSPR 27.23
- Support Level
- MVBF $23.90
- JSPR $2.50
- Resistance Level
- MVBF $24.37
- JSPR $2.87
- Average True Range (ATR)
- MVBF 0.46
- JSPR 0.13
- MACD
- MVBF -0.00
- JSPR -0.01
- Stochastic Oscillator
- MVBF 87.36
- JSPR 8.96
About MVBF MVB Financial Corp.
MVB Financial Corp is a bank holding company. The company provides Personal banking, Business banking, and Fintech solutions. The group has identified three reportable segments: CoRe Banking, Mortgage Banking, and Financial Holding Company. The majority of ts revenue generated from the CoRe Banking segment, which includes the Fintech division, represents banking products and services offered to customers by the Bank, loans, and deposit accounts. Revenue from banking activities consists of interest earned on loans and investment securities and service charges on deposit accounts.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.